首页 | 本学科首页   官方微博 | 高级检索  
     


Matrix metalloproteinase‐11 as a marker of metastasis and predictor of poor survival in urothelial carcinomas
Authors:Wei‐Ming Li MD  Yu‐Ching Wei MD  Chun‐Nung Huang MD  PhD  Hung‐Lung Ke MD  Ching‐Chia Li MD  Hsin‐Chih Yeh MD  Lin‐Li Chang PhD  Chun‐Hsiung Huang MD  PhD  Chien‐Feng Li MD  PhD  Wen‐Jeng Wu MD  PhD
Affiliation:1. Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan;2. Department of Urology, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan;3. Department of Urology, School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan;4. Department of Urology, Ministry of Health and Welfare Pingtung Hospital, Pingtung, Taiwan;5. Department of Pathology, Kaohsiung Municipal Ta‐Tung Hospital, Kaohsiung, Taiwan;6. Department of Urology, Kaohsiung Municipal Ta‐Tung Hospital, Kaohsiung, Taiwan;7. Department of Microbiology, School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan;8. Department of Biotechnology, Southern Taiwan University of Science and Technology, Tainan, Taiwan;9. Department of Pathology, Chi‐Mei Medical Center, Tainan, Taiwan;10. National Cancer Research Institute, National Health Research Institutes, Tainan, Taiwan;11. Institute of Clinical Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan;12. Department of Internal Medicine and Cancer Center, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan;13. Center for Infectious Disease and Cancer Research, Kaohsiung Medical University, Kaohsiung, Taiwan;14. Center for Stem Cell Research, Kaohsiung Medical University, Kaohsiung, Taiwan
Abstract:
Keywords:MMP‐11  urothelial carcinoma  bladder cancer  upper urinary tract urothelial carcinoma  prognosis
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号